An immune system kinase promotes tumor inflammation and progression, according to a study published in Nature Communications.
An epigenetic inhibitor increased immune system activity in patients with ovarian cancer.
Investigators have discovered novel cellular pathways behind chemotherapy-resistant glioblastoma cells and a potential biomarker, paving the way for new therapeutic targets.
Northwestern Medicine investigators have discovered novel mechanisms that regulate cellular stress response, according to findings published in the Proceedings of the National Academy of Sciences.
Bicarbonate ions are required for cell growth in some cancers, according to a Northwestern Medicine study.
In adult patients undergoing cancer treatment, weekly electronic symptom monitoring significantly improved quality of life, according to a recent study published in JAMA.
An enzymatic modifier of messenger RNA has different functions depending on its location, according to a recent study.
A new study provides evidence that blood epigenetic biomarkers contain “snapshots” of past cardiovascular health exposures and behavior at the molecular level.
Proteins gain new interactions that are potentially oncogenic and could drive cancer development and growth, according to a recent study.
Patients with advanced kidney cancer who received a new combination treatment reported improved health-related quality of life outcomes, according to a Northwestern Medicine study.